Synthesis and determination of chronic and acute thermal and chemical pain activities of a new derivative of phencyclidine in rats

Iranian Journal of Pharmaceutical Research

Volumn 9, Issue 4, 2010, Pages 379-385

  Ahmadi, Abbas ^a   Khalili, Mohsen ^b   Hajikhani, Ramin ^a   Barghi, Leila ^a   Mihandoust, Farnaz ^a  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b SHAHED UNIVERSITY   (Iran)

Author keywords

1 tetralone derivatives; Acute and chronic pain; Formalin test; Ketamine; Phencyclidine; Tail immersion test

Indexed keywords

1 [1 (3 METHOXYPHENYL)(TETRALYL)]PIPERIDINE; ANALGESIC AGENT; KETAMINE; PHENCYCLIDINE; PHENCYCLIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CHRONIC PAIN; DRUG SYNTHESIS; FEMALE; NONHUMAN; PAIN; PAIN ASSESSMENT; RAT;

EID: 78651255835     PISSN: 17350328     EISSN: 17266890     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Chen G, Ensor CR, Russell D and Bohner B. The pharmacology of 1-(1-phenylcyclohexyl) piperidine HCl. J. Pharmacol. Exp. Ther. (1959) 127: 241-250.
2. Honey CR, Miljkovic Z and McDonald JF. Ketamine and phencyclidine cause a voltage-dependent block of responses to L-aspartic acid. Neurosci. Lett. (1985) 61 135-139.
3. Domino EF, Chodoff P and Corssen G. Pharmacologic Effects of Ci-581 (A new dissociative anesthetic). Man. Clin. Pharmacol. Ther. (1965) 6: 279-291.
4. Anis NA, Berry SC and Burton NR. The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate. Br. J. Pharmacol. (1983) 79: 565-575.
5. Tabrizian K, Najafi S, Belaran M, Hosseini-Sharifabad A, Azemi Hosseini A, Soodi M, Kazemi A, Kebriaeezadeh A and Sharifzadeh M. Effects of selective iNOS inhibitor on spatial memory in recovered and non-recovered ketamine induced-anesthesia in wistar rats. Iranian J. Pharm. Res. (2010) 9: 313-320.
6. Monaghan DT, Bridges RJ and Cotman CW. The excitatory amino acid receptors: their classes, pharmacology, and distinct properties in the function of the central nervous system. Annu. Rev. Pharmacol. Toxicol. (1989) 29: 365-402.
7. Ahmadi A and Mahmoudi A. Synthesis with improved yield and study on analgesic effect of 2-methoxyphencyclidine. Arzneim-Forsch-Drug Res. (2006) 56: 346-350.
8. Al-deeb OAA. Synthesis and analgesic activity of new phencyclidine derivatives. Arzneim-Forsch-Drug Res. (1994) 44: 1141-1144.
9. Ahmadi A and Mahmoudi A. Synthesis and biological properties of 2- hydroxy-1-(1-phenyltetralin) piperidine and some of its intermediates as derivatives of phencyclidine. Arzneim-Forsch-Drug Res. (2005) 55: 528-532.
10. Shimoyama N, Shimoyama M and Inturrisi CE. Ketamine attenuates reverses morphine tolerance in rodents. Anesthesiol. (1996) 85: 1357-1366.
11. Fuman B, Aldinger G, Fauman M and Rosen P. Psychiatric Squeal of phencyclidine abuse. Clin. Toxicol. (1976) 9: 529-538.
12. Al-deeb OAA. New analgesic derived from the phencyclidine analogue thiencyclidine. Arzneim-Forsch-Drug Res. (1996) 46: 505-508.
13. Ogunbadeniyi AM and Adejare A. Syntheses of fluorinated phencyclidine analogs. J. Fluo. Chem. (2002) 114: 39-42.
14. Ahmadi A, Shafiezadeh M and Fathollahi Y. Synthesis with improved yield and study on analgesic effect of 2-hydroxyphencyclidine. Arzneim-Forsch-Drug Res. (2005) 55: 172-176.
15. Kamenka JM, Ung MSN and Herrmann P. Determination conformationnelle de derives de la phencyclidine en vue d'une correlation acture-active. Eur. J. Med. Chem. Therapeutica (1979) 14: 301-308.
16. Kamenka JM, Chiche B, Goudal R, Geneste P, Vignon J and Vincent JP. Chemical synthesis and molecular pharmacology of hydroxylated 1-(1-phenylcyclohexyl) piperidine derivatives. J. Med. Chem. (1982) 25: 431-435.
17. Itzhak Y, Kalir A, Weissman BA and Cohen S. New analgesic drugs derived from phencyclidine. J. Med. Chem. (1981) 24: 496-499
18. Ahmadi A, Khalili M, Abbassi S, Javadi M, Mahmoudi A and Hajikhani R. Synthesis and study on analgesic effects of 1-[1-(4-methylphenyl) (cyclohexyl)] 4-piperidinol and 1-[1-(4-methoxyphenyl) (cyclohexyl)] 4-piperidinol as two new phencyclidine derivatives. Arzneim-Forsch-Drug Res. (2009) 59: 202-206.
19. Darvich MR and Zonoozi A. Preparation of the phencyclidine analogues (part II). Iran. J. Chem. & Chem. Eng. (1993) 2: 17-20.
20. Kaorv H. O-H stretching absorption and conformation of the β-methyl derivatives of 1-tetralol, 4-chromanol, 4-thiochromanol, and 4-thiochromanol 1, 1-dioxide. Bull. Chem. Soc. Jpn. (1974) 47: 2607-2608.
21. Nobuo M, Mitsuo Y, Yoshihiro A and Yojiro T. Intramolecular hydrogen bonds. XVI. Preferable conformation of 1-tetralols. Bull. Chem. Soc. Jpn. (1971) 44: 1137-1139.
22. Geneste P, Kamenka JM and Dessapt P. Method for stereoselective production of substituted cyclohexylcyanhydrines. Bull. Soc. Chim. Fr. (1980) 2: 187-191.
23. Ramabadran K, Bansinath M, Turndorf H and Puig MM. Tail immersion test for the evaluation of a nociceptive reaction in mice. Methodological considerations. J. Pharmacol. Methods (1989) 21: 21-31.
24. Hamura H, Yoshida M, Shimizu K, Matsukura T, Suzuki H and Narita M. Antinociceptive effect of the combination of pentazocine with morphine in the tail-immersion and scald-pain tests in rats. Jpn. J. Pharmacol. (2000) 83: 286-292.
25. Molina N, Bedran-de-Castro MT and Bedran-de-Castro JC. Sex-related differences in the analgesic response to the rat tail immersion test. Braz. J. Med. Biol. Res. (1994) 27: 1669-1672.
26. Ibba M, Schiavi S, Abbiati G and Testa R. Effects of oral administration of nortriptyline, imipramine and citalopram on morphine hot-plate and tail-immersion analgesia in rats. Bull. Chim. Farm. (1987) 126: 75-80.
27. Sewell RD and Spencer PS. Antinociceptive activitiy of narcotic agonist and partial agonist analgesics and other agents in the tail-immersion test in mice and rats. Neuropharmacol. (1976) 15: 683-688.
28. Padi SSV and Kulkarni SK. Minocycline prevents the development of neuropathic pain, but not acute pain: Possible anti-inflammatory and antioxidant mechanisms. Eur. J. Pharm. (2008) 601: 79-87.
29. Ibrahim MM, Rude ML, Stagg NJ, Mata HP, Lai J, Vanderah TW, Porreca F, Buckley NE, Makriyannis A and Malan JTP. CB2 cannabinoid receptor mediation of antinociception. Pain (2006) 122: 36-42.
30. Shams J, Sahraei H, Faghih-Monzavi Z, Salimi SH, Fatemi SM, Pourmotabbed A, Ghoshooni H and Kamalinejad M. Effects of Papaver rhoeas extract on the tolerance development to analgesic effects of morphine in mice. Iranian J. Pharm. Res. (2008) 7: 141-147.
31. Jones LA, Beaver RW, Schmoeger TL, Ort JF, Leander JD. Isolation, Identification and synthesis of compounds cosynthesized in the preparation of phencyclidine. J. Org. Chem. (1981) 46: 3330-3333.
32. Parsons CG, Gibbens H and Magnago TSL. At which 'sigma' site are the spinal actions of ketamine mediated? Neurosci. Lett. (1988) 85: 322-328.
33. Qian J, Brown SD and Carlton SM. Systemic ketamine attenuates nociceptive behaviors in a rat model of peripheral neuropathy. Brain Res. (1996) 715: 51-62.
34. Bonnefont J, Alloui A, Chapuy E, Clottes E and Eschalier A. Orally administered paracetamol does not act locally in the rat formalin test: evidence for a supraspinal, serotonin-dependent antinociceptive mechanism. Anesthesiol. (2003) 99: 976-81.